Gemcitabine plus vinorelbine for the treatment of advanced non-small cell lung cancer

European Journal of Cancer

Volumn 37, Issue 11, 2001, Pages 1381-1384

  Baron F ^a   Cueva, J ^a   Grana B ^a   Curiel, T ^a   Leon L ^a   Vazquez F ^a   Candamio, S ^a   Lopez R ^a  

^a Instituto de Salud Carlos III   (Spain)

Author keywords

Gemcitabine; Non small cell lung cancer; Toxicity; Vinorelbine

Indexed keywords

GEMCITABINE; NAVELBINE;

ADULT; AGED; ALOPECIA; ANEMIA; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG TOLERABILITY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MALE; MUCOSA INFLAMMATION; NAUSEA AND VOMITING; NEPHROTOXICITY; NEUROTOXICITY; NEUTROPENIA; PRIORITY JOURNAL; THROMBOCYTOPENIA;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; DEOXYCYTIDINE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VINBLASTINE;

EID: 0034962362     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(01)00129-0     Document Type: Article

References (18)

1. Non small cell lung cancer
2. Chemotherapy in non-small cell lung cancer: A meta-analysis using updates data on individual patients from 52 randomized clinical trials
3. Survival determinates in extensive non-small cell lung cancer
4. Clinical practice guidelines for the treatment of unresectable non small cell lung cancer
5. Single agent activity of weekly gemcitabine in advanced non small cell lung cancer: A phase II study
6. A phase II study of navelbine in the treatment of non small cell lung cancer
7. In vitro interaction between gemcitabine and other anticancer drugs using novel three-dimensional model
8. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial
9. A randomized phase III trial of four chemotherapy regimens in advanced non-small cell lung cancer (NSCLC)
10. Randomized comparation of two combination regimens versus minimal chemotherapy in non small cell lung cancer
11. Mitomycin C plus vindesine plus etoposide (MVP) versus mitomycin plus vindesine plus cisplatin (MVP) in stage IV non-small-cell-lung cancer. A phase III multicentre randomized trial
12. Phase I-II study of gemcitabine plus vinorelbine in non-small cell lung cancer
13. Phase I/II of gemcitabine plus vinorelbine as first line chemoterapy of non small-cell-lung cancer
14. Phase II of vinorelbine and gemcitabine for inoperable stage IIIB-IV non-small-cell lung cancer
15. Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non small cell lung cancer
16. A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma
17. A phase III trial of 5-fluorouracil and leucovorin in the treatment of advanced colorectal cancer
18. The interface between oncology and palliative medicine